497 related articles for article (PubMed ID: 18254017)
1. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
Hartweg J; Perera R; Montori V; Dinneen S; Neil HA; Farmer A
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003205. PubMed ID: 18254017
[TBL] [Abstract][Full Text] [Related]
2. Fish oil in people with type 2 diabetes mellitus.
Farmer A; Montori V; Dinneen S; Clar C
Cochrane Database Syst Rev; 2001; (3):CD003205. PubMed ID: 11687050
[TBL] [Abstract][Full Text] [Related]
3. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Martin N; Bridges C; Brainard JS; Wang X; Brown TJ; Hanson S; Jimoh OF; Ajabnoor SM; Deane KH; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012345. PubMed ID: 30019767
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
Hartweg J; Farmer AJ; Perera R; Holman RR; Neil HA
Diabetologia; 2007 Aug; 50(8):1593-602. PubMed ID: 17541540
[TBL] [Abstract][Full Text] [Related]
5. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
Brown TJ; Brainard J; Song F; Wang X; Abdelhamid A; Hooper L;
BMJ; 2019 Aug; 366():l4697. PubMed ID: 31434641
[TBL] [Abstract][Full Text] [Related]
6. Omega 6 fatty acids for the primary prevention of cardiovascular disease.
Al-Khudairy L; Hartley L; Clar C; Flowers N; Hooper L; Rees K
Cochrane Database Syst Rev; 2015 Nov; (11):CD011094. PubMed ID: 26571451
[TBL] [Abstract][Full Text] [Related]
7. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
Marston NA; Giugliano RP; Im K; Silverman MG; O'Donoghue ML; Wiviott SD; Ference BA; Sabatine MS
Circulation; 2019 Oct; 140(16):1308-1317. PubMed ID: 31530008
[TBL] [Abstract][Full Text] [Related]
8. Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials.
Gao C; Liu Y; Gan Y; Bao W; Peng X; Xing Q; Gao H; Lai J; Liu L; Wang Z; Yang Y
Lipids Health Dis; 2020 May; 19(1):87. PubMed ID: 32384902
[TBL] [Abstract][Full Text] [Related]
9. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.
Malhotra A; Shafiq N; Arora A; Singh M; Kumar R; Malhotra S
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001918. PubMed ID: 24913720
[TBL] [Abstract][Full Text] [Related]
10. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
Sydenham E; Dangour AD; Lim WS
Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids for intermittent claudication.
Campbell A; Price J; Hiatt WR
Cochrane Database Syst Rev; 2013 Jul; (7):CD003833. PubMed ID: 23824785
[TBL] [Abstract][Full Text] [Related]
12. The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials.
Chewcharat A; Chewcharat P; Rutirapong A; Papatheodorou S
PLoS One; 2020; 15(2):e0228315. PubMed ID: 32045421
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
14. Dietary fibre for the primary prevention of cardiovascular disease.
Hartley L; May MD; Loveman E; Colquitt JL; Rees K
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011472. PubMed ID: 26758499
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids for intermittent claudication.
Sommerfield T; Price J; Hiatt WR
Cochrane Database Syst Rev; 2007 Oct; (4):CD003833. PubMed ID: 17943801
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
[TBL] [Abstract][Full Text] [Related]
17. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis.
Barkas F; Nomikos T; Liberopoulos E; Panagiotakos D
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823643
[TBL] [Abstract][Full Text] [Related]
18. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Omega-3 Polyunsaturated Fatty Acids Supplementation in Managing Overweight and Obesity: A Meta-Analysis of Randomized Clinical Trials.
Zhang YY; Liu W; Zhao TY; Tian HM
J Nutr Health Aging; 2017; 21(2):187-192. PubMed ID: 28112774
[TBL] [Abstract][Full Text] [Related]
20. Safety in the hypertriglyceridemia treatment with N-3 polyunsaturated fatty acids on glucose metabolism in subjects with type 2 diabetes mellitus.
Reis CE; Landim KC; Nunes AC; Dullius J
Nutr Hosp; 2014 Oct; 31(2):570-6. PubMed ID: 25617537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
